Results 311 to 320 of about 169,022 (378)

Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins

, 2001
Julie A. Wilson, Mike Bray, Russell R. Bakken, Mary Kate Hart   +3 more
openalex   +1 more source

In silico design of Ebola virus Glycoprotein antigenic peptides as vaccine candidates. [PDF]

PLoS One
Lara-Ramírez D, Santacruz-Tinoco CE, Ramón-Gallegos E, Muñoz-Medina JE.   +3 more
europepmc   +1 more source

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022

Mass Spectrometry Reviews, Volume 44, Issue 3, Page 213-453, May/June 2025.
Abstract The use of matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this review is the 12th update of the original article published in 1999 and brings coverage of the literature to the end of 2022.
David J. Harvey
wiley   +1 more source

Mapping Immunological, Host Receptor Binding Determinants, and Cathepsin Cleavage Site of EBOV Glycoprotein Utilizing the Qubevirus Platform. [PDF]

ACS Omega
Ntemafack A, Dzelamonyuy A, Nchinda G, Bopda Waffo A.   +3 more
europepmc   +1 more source

Bat‐Borne RNA Viruses: Addressing the Rising Health Risks in Bangladesh

Public Health Challenges, Volume 4, Issue 2, June 2025.
Md Nasir Ahmed
wiley   +1 more source

Vesicular Release of Ebola Virus Matrix Protein VP40

, 2001
Joanna Timmins, Sandra Scianimanico, Guy Schoehn, Winfríed Weissenhorn   +3 more
openalex   +1 more source

Therapeutic strategies to target the Ebola virus life cycle

Nature Reviews Microbiology, 2019
T. Hoenen, A. Groseth, H. Feldmann
semanticscholar   +1 more source

Ophthalmological manifestations and plasma markers of inflammation in Ebola survivors in post-treatment era. [PDF]

Sci Rep
Mwanza JC, Kahindo AK, Mbusa-Kombi J, Mumbere MV, Kitenge RO, McIlwain DR, Mulangu JCS, Mbala PK, Okitundu D, Giordani BJ, Boivin MJ, Sikorskii A, Kabedi NN, Shantha JG, Yeh S, Mumba DN, Tshala-Katumbay D.   +16 more
europepmc   +1 more source

Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses

MedComm, Volume 6, Issue 5, May 2025.
Multispecific antibodies harness the advantages of two or more mAbs. In this study, we designed novel trispecific antibodies, Tri‐1 and Tri‐2, derived from our previously identified mAbs, PW5‐5, PW5‐535, and PW5‐570. These trispecific antibodies exhibited enhanced binding affinity and broad neutralization capacity against SARS‐CoV, SARS‐CoV‐2 variants,
Rui Qiao, Yuanchen Liu, Qiyu Mao, Jiayan Li, Yinying Lu, Jialu Shi, Chen Li, Jizhen Yu, Jiami Gong, Xun Wang, Yuchen Shao, Lei Sun, Wenhong Zhang, Hongjie Yu, Hin Chu, Pengfei Wang, Xiaoyu Zhao   +16 more
wiley   +1 more source

Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein

, 2001
Masayuki Saijo, Masahiro Niikura, Shigeru Morikawa, Ichiro Kurane   +3 more
openalex   +1 more source